{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:56:07Z","timestamp":1787748967881,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council, Singapore","doi-asserted-by":"crossref","award":["NMRC\/CIRG\/1350\/2013"],"award-info":[{"award-number":["NMRC\/CIRG\/1350\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00270-022-03073-7","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T23:02:32Z","timestamp":1646262152000},"page":"1663-1669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-Effectiveness of Drug-Coated Balloon Angioplasty Versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Chronic Limb-Threatening Ischemia: The SINGA-PACLI Trial"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8316-0450","authenticated-orcid":false,"given":"Nirmali","family":"Sivapragasam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Matchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Da","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uei","family":"Pua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlaing Hlaing","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivanathan","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda","family":"Venkatanarasimha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine M. E.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn Wei Leong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah G.","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sum","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiang Hiong","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Tec","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bien Soo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"18","key":"3073_CR1","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jacc.2016.04.071","volume":"68","author":"MH Shishehbor","year":"2016","unstructured":"Shishehbor MH, et al. Critical limb ischemia: an expert statement. J Am Coll Cardiol. 2016;68(18):2002\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3073_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1078-5884(97)80203-1","volume":"14","author":"The i.c.a.i, G","year":"1997","unstructured":"The i.c.a.i, G. Long-term mortality and its predictors in patients with critical leg ischaemia. Eur J Vas Endovas Surg. 1997;14(2):91\u20135.","journal-title":"Eur J Vas Endovas Surg"},{"issue":"6","key":"3073_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ejvs.2005.02.035","volume":"29","author":"E Faglia","year":"2005","unstructured":"Faglia E, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29(6):620\u20137.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"3073_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejvs.2008.12.001","volume":"37","author":"R Ferraresi","year":"2009","unstructured":"Ferraresi R, et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2009;37(3):336\u201342.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"3073_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jvs.2012.12.069","volume":"57","author":"SM Seedial","year":"2013","unstructured":"Seedial SM, et al. Local drug delivery to prevent restenosis. J Vasc Surg. 2013;57(5):1403\u201314.","journal-title":"J Vasc Surg"},{"issue":"2","key":"3073_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373(2):145\u201353.","journal-title":"N Engl J Med"},{"issue":"5","key":"3073_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495\u2013502.","journal-title":"Circulation"},{"issue":"1","key":"3073_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jvs.2017.06.112","volume":"67","author":"ND Sridharan","year":"2018","unstructured":"Sridharan ND, et al. Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery. J Vasc Surg. 2018;67(1):343\u201352.","journal-title":"J Vasc Surg"},{"issue":"22","key":"3073_CR9","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jcin.2016.08.036","volume":"9","author":"AC Salisbury","year":"2016","unstructured":"Salisbury AC, et al. Cost-effectiveness of endovascular femoropopliteal intervention using drug-coated balloons versus standard percutaneous transluminal angioplasty: results from the IN.PACT SFA II Trial. JACC Cardiovas Interv. 2016;9(22):2343\u201352.","journal-title":"JACC Cardiovas Interv"},{"issue":"6","key":"3073_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","volume":"128","author":"F Liistro","year":"2013","unstructured":"Liistro F, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013;128(6):615\u201321.","journal-title":"Circulation"},{"issue":"8","key":"3073_CR11","first-page":"205","volume":"31","author":"JA Mustapha","year":"2019","unstructured":"Mustapha JA, et al. Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the lutonix BTK trial. J Invasive Cardiol. 2019;31(8):205\u201311.","journal-title":"J Invasive Cardiol"},{"issue":"15","key":"3073_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","volume":"64","author":"T Zeller","year":"2014","unstructured":"Zeller T, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am College Cardiol. 2014;64(15):1568\u201376.","journal-title":"J Am College Cardiol"},{"issue":"12","key":"3073_CR13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"T Zeller","year":"2015","unstructured":"Zeller T, et al. Paclitaxel-Coated Balloon in Infrapopliteal\u00a0Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK\u2019S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC Cardiovasc Interv. 2015;8(12):1614\u201322.","journal-title":"JACC Cardiovasc Interv"},{"key":"3073_CR14","doi-asserted-by":"crossref","unstructured":"Ipema, J., et al., Editor's Choice \u2013 Drug Coated Balloon Angioplasty vs. Standard Percutaneous Transluminal Angioplasty in Below the Knee Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. European journal of vascular and endovascular surgery, 2020. 59(2): p. 265\u2013275.","DOI":"10.1016\/j.ejvs.2019.10.002"},{"issue":"19","key":"3073_CR15","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jcin.2020.06.045","volume":"13","author":"F Liistro","year":"2020","unstructured":"Liistro F, et al. Randomized controlled trial of acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty. JACC Cardiovasc Interv. 2020;13(19):2277\u201386.","journal-title":"JACC Cardiovasc Interv"},{"issue":"26","key":"3073_CR16","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","volume":"383","author":"J Nordanstig","year":"2020","unstructured":"Nordanstig J, et al. Mortality with paclitaxel-coated devices in peripheral artery disease. N Engl J Med. 2020;383(26):2538\u201346.","journal-title":"N Engl J Med"},{"issue":"2","key":"3073_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1526602820969681","volume":"28","author":"X Jia","year":"2020","unstructured":"Jia X, et al. Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of infrapopliteal artery lesions (AcoArt II\u2013BTK). J Endovasc Ther. 2020;28(2):215\u201321.","journal-title":"J Endovasc Ther"},{"issue":"8","key":"3073_CR18","first-page":"Cd011319","volume":"2016","author":"A Kayssi","year":"2016","unstructured":"Kayssi A, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Datab Syst Rev. 2016;2016(8):Cd011319.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"3","key":"3073_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1148\/radiol.2021204294","volume":"300","author":"A Patel","year":"2021","unstructured":"Patel A, et al. Randomized controlled trial comparing drug-coated balloon angioplasty versus conventional balloon angioplasty for treating below-the-knee arteries in critical limb Ischemia: The SINGA-PACLI trial. Radiology. 2021;300(3):715\u201324.","journal-title":"Radiology"},{"issue":"3","key":"3073_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford RB, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517\u201338.","journal-title":"J Vasc Surg"},{"key":"3073_CR21","unstructured":"World Bank. Official exchange rate (LCU per US$, period average). World Development Indicators 2021 [cited 2021 13th January]"},{"issue":"1","key":"3073_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53\u201372.","journal-title":"Health Policy"},{"issue":"2","key":"3073_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127\u201337.","journal-title":"Appl Health Econ Health Policy"},{"issue":"11","key":"3073_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095\u2013108.","journal-title":"Med Care"},{"key":"3073_CR25","unstructured":"Neumann, P.J., et al. Cost-effectiveness in health and medicine. Oxford University Press; 2016"},{"issue":"2","key":"3073_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","volume":"18","author":"SD Ramsey","year":"2015","unstructured":"Ramsey SD, et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR good research practices task force report. Value Health. 2015;18(2):161\u201372.","journal-title":"Value Health"},{"key":"3073_CR27","unstructured":"Baltussen, R., et al. Making choices in health: WHO guide to cost-effectiveness analysis. World Health Organization; 2003"},{"key":"3073_CR28","unstructured":"StataCorp. Stata statistical software: release 16. StataCorp LLC: College Station, TX; 2019."},{"issue":"4","key":"3073_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ccd.25536","volume":"84","author":"JB Pietzsch","year":"2014","unstructured":"Pietzsch JB, et al. Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany: Economics of PAD Endovascular Interventions. Catheter Cardiovasc Interv. 2014;84(4):546\u201354.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"3073_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00270-019-02385-5","volume":"43","author":"T Wakkie","year":"2020","unstructured":"Wakkie T, et al. Cost-effectiveness of drug-eluting stents for infrapopliteal lesions in patients with critical limb ischemia: the PADI trial. Cardiovasc Intervent Radiol. 2020;43(3):376\u201381.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3073_CR31","doi-asserted-by":"crossref","unstructured":"Salisbury, A.C.M.D.M., et al. Cost-effectiveness of endovascular femoropopliteal intervention using drug-coated balloons\u00a0versus standard percutaneous transluminal angioplasty. JACC Cardiovas Intervent. 2016;9(22):2343\u20132352","DOI":"10.1016\/j.jcin.2016.08.036"},{"key":"3073_CR32","doi-asserted-by":"crossref","unstructured":"Pellegrini D, Di Palma G, Cortese B. Cost\/effectiveness and reimbursement policies with drug-coated balloons in Europe. Cham: Springer International Publishing; 2019; p. 219\u2013226","DOI":"10.1007\/978-3-319-92600-1_21"},{"key":"3073_CR33","doi-asserted-by":"crossref","unstructured":"Spreen, M.I., et al. Percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia (PADI) trial. Circ Cardiovasc Interv. 2016;9(2):e002376","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376"},{"issue":"22","key":"3073_CR34","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","volume":"60","author":"D Scheinert","year":"2012","unstructured":"Scheinert D, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol. 2012;60(22):2290\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3073_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","volume":"55","author":"M Bosiers","year":"2012","unstructured":"Bosiers M, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55(2):390\u20138.","journal-title":"J Vasc Surg"},{"issue":"7","key":"3073_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","volume":"60","author":"A Rastan","year":"2012","unstructured":"Rastan A, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012;60(7):587\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3073_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldq033","volume":"96","author":"SJ Whitehead","year":"2010","unstructured":"Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96(1):5\u201321.","journal-title":"Br Med Bull"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03073-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T17:09:45Z","timestamp":1667322585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03073-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3073"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03073-7","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"11 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Ethical approval of the study protocol was obtained from the institutional review board at each study site.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standard"}},{"value":"Informed consent was obtained from all individual participants included in the study. Consent for publication was obtained for every individual person\u2019s data included in the study.***","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}